footandmouth
diseas
fmd
highli
contagi
diseas
affect
clovenhoof
anim
includ
cattl
swine
sheep
goat
lot
wild
speci
effect
control
measur
urg
need
show
homoharringtonin
treatment
exhibit
strong
inhibitori
effect
two
differ
strain
fmdv
swine
kidney
cell
experi
demonstr
homoharringtonin
affect
viru
attach
entri
use
timeofaddit
assay
found
antivir
activ
homoharringtonin
occur
primarili
earli
stage
infect
result
demonstr
homoharringtonin
might
effect
antifmdv
drug
studi
requir
explor
antivir
activ
homoharringtonin
fmdv
replic
vivo
k
e
w
r
antivir
fmdv
homoharringtonin
rna
viru
viral
replic
footandmouth
diseas
fmd
one
contagi
diseas
clovenhoof
anim
great
potenti
caus
sever
econom
loss
suscept
farm
gener
clinic
symptom
infect
anim
cattl
pig
sheep
goat
character
vesicl
feet
around
mouth
mammari
gland
femal
seven
serotyp
fmdv
name
c
asia
infect
serotyp
confer
immun
other
vaccin
current
prefer
method
prevent
fmdv
infect
howev
vaccin
provid
complet
clinic
protect
anim
least
day
vaccin
addit
emerg
vaccin
serotyp
subtyp
specif
result
use
often
requir
specif
diagnost
test
distinguish
vaccin
unvaccin
anim
altern
strategi
use
use
immunomodulatori
antivir
molecul
induc
immedi
serotyp
nonspecif
protect
anim
fmdv
infect
viral
protein
need
lot
viru
form
new
particl
process
reli
cellular
translat
machineri
thu
inhibit
protein
translat
process
may
becom
new
antivir
therapeut
strategi
control
infect
date
number
compound
includ
silvestrol
hippuristanol
rocaglamid
elisabatin
allolaurintenol
identifi
specif
effect
inhibit
translat
process
homoharringtonin
known
inhibit
first
cycl
elong
phase
eukaryot
translat
homoharringtonin
use
china
treatment
chronic
myeloid
leukemia
cml
type
tumor
diseas
past
year
besid
homoharringtonin
report
exhibit
antivir
activ
hepat
b
viru
hbv
bovin
viral
diarrhea
viru
bvdv
chikungunya
viru
mous
hepat
coronaviru
varicellazost
viru
vesicular
stomat
viru
vsv
newcastl
diseas
viru
ndv
porcin
epidem
diarrhea
viru
pedv
type
herp
simplex
viru
pseudorabi
viru
prv
characterist
make
homoharringtonin
attract
candid
develop
antivir
therapeut
activ
fmdv
remain
unexplor
current
studi
inhibitori
effect
homoharringtonin
fmdv
replic
cell
demonstr
also
studi
investig
potenti
mechan
homoharringtonin
could
exert
antivir
effect
provid
preliminari
evid
possibl
use
antivir
agent
earli
stage
viral
infect
cytotox
evalu
use
oduntr
absorb
obtain
untreat
cell
odtreat
repres
absorb
valu
treat
cell
hour
post
infect
cell
lysat
subject
three
freezethaw
cycl
prepar
determin
fmdv
mrna
protein
level
qpcr
western
blot
analysi
respect
collect
cell
lyse
use
pierc
radioimmunoprecipit
assay
ripa
buffer
thermo
fisher
scientif
uk
incub
ice
half
hour
centrifug
g
minut
supernat
collect
use
determin
determin
inhibitori
effect
homoharringtonin
fmdv
infect
viral
mrna
measur
qpcr
previous
describ
modif
briefli
collect
cell
subject
rna
extract
trizol
reagent
invitrogen
concentr
requir
reduc
virusinduc
cytopathogen
control
valu
ec
calcul
graphpad
prism
graphpad
softwar
inc
la
jolla
ca
select
indic
si
deriv
si
cc
ec
statist
signific
analyz
student
test
valu
p
consid
signific
data
present
mean
sd
viru
bind
assay
viru
entri
assay
carri
describ
previous
usual
virus
attach
cell
receptor
enter
cell
temperatur
rise
accord
featur
studi
perform
evalu
whether
homoharringtonin
suppress
fmdv
attach
entri
figur
indic
homoharringtonin
exhibit
signific
inhibit
capac
fmdv
bind
entri
stage
determin
time
infect
observ
viral
attach
entri
affect
treatment
homoharringtonin
timeofaddit
studi
also
perform
identifi
window
fmdv
replic
cycl
homoharringtonin
exhibit
antivir
effect
studi
reveal
f
g
u
r
e
evalu
effect
homoharringtonin
ifa
cell
infect
fmdv
moi
hour
cell
treat
indic
concentr
homoharringtonin
hour
dmso
mock
ifa
perform
fluoresc
observ
use
fluoresc
microscop
dmso
dimethyl
sulfoxid
ifa
immunofluoresc
assay
f
g
u
r
e
homoharringtonin
effect
viru
attach
entri
rel
viral
rna
level
cell
treat
homoharringtonin
viral
attach
stage
b
rel
viral
rna
level
cell
treat
homoharringtonin
viral
entri
stage
differ
suppress
compar
dmso
group
assess
analysi
varianc
follow
student
test
data
express
mean
sd
three
independ
experi
homoharringtonin
remain
potent
ad
post
infect
hour
hour
post
infect
indic
inhibitori
effect
homoharringtonin
fmdv
replic
occur
primarili
earli
stage
similar
result
also
obtain
studi
dong
et
al
studi
found
homoharringtonin
play
role
viral
replic
cycl
viral
entri
although
homoharringtonin
show
broad
antivir
activ
lot
viru
cell
cultur
vsv
ndv
pedv
prv
etc
action
report
restrict
rna
virus
exampl
dong
et
al
report
homoharringtonin
treatment
moder
inhibit
infect
avian
influenza
viru
studi
found
homoharringtonin
exert
antivir
activ
fmdv
porcin
picornavirida
includ
two
differ
strain
fmdv
therefor
studi
broaden
understand
characterist
antivir
activ
studi
need
investig
inhibitori
effect
homoharringtonin
fmdv
infect
vivo
conclus
demonstr
fmdv
infect
inhibit
dose
time
depend
manner
homoharringtonin
treatment
furthermor
homoharringtonin
specif
target
viru
earli
phase
viral
replic
result
indic
homoharringtonin
could
becom
promis
candid
develop
fmdv
inhibitor
research
requir
explor
whether
homoharringtonin
antivir
effect
vivo
